Novaliq Gmbh Is A Biopharmaceutical Company Based In Heidelberggermanywith A Subsidiary In Cambridgemassachusettsthe Company Specializes In Innovative Ocular Therapeuticsfocusing On Developing Advanced Treatments For Eye Diseasesparticularly Dry Eye Diseasededand Glaucomanovaliq Utilizes Its Proprietary Eyesolatechnologya Water Free Drug Delivery Platform That Enhances The Bioavailability And Efficacy Of Ophthalmic Medications The Company Aims To Address Significant Gaps In Eye Caretargeting The U Smarket Where Millions Of Patients Are Affected By Ded And Glaucomanovaliq S Product Pipeline Includes Therapies For Ded And Glaucoma Treatments Developed Through Its Joint Venturebetaliq Incthe Company Has Raised $115 Million In Capitalreflecting Strong Investor Confidence And Commitment To Expanding Its Market Presencewith A Focus On Strategic Partnerships And Innovative Solutionsnovaliq Is Positioned To Redefine Treatment Paradigms In Ocular Therapeutics
No conferences found for this company.
| Company Name | Novaliq Gmbh |
| Country |
Germany
|
| Address | N/A |
| Telephone | N/A |
| N/A |
